UY32498A - Reconstitución in situ de una vacuna para la administración a un grupo de animales predeterminado - Google Patents

Reconstitución in situ de una vacuna para la administración a un grupo de animales predeterminado

Info

Publication number
UY32498A
UY32498A UY0001032498A UY32498A UY32498A UY 32498 A UY32498 A UY 32498A UY 0001032498 A UY0001032498 A UY 0001032498A UY 32498 A UY32498 A UY 32498A UY 32498 A UY32498 A UY 32498A
Authority
UY
Uruguay
Prior art keywords
vaccine
default
administration
animals group
situ
Prior art date
Application number
UY0001032498A
Other languages
English (en)
Inventor
Alexander Albertus Stephanus Eggen
Gozio Stefano
Carla Christina Schrier
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of UY32498A publication Critical patent/UY32498A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Surgical Instruments (AREA)

Abstract

La invención también se refiere a un método para producir múltiples antígenos inactivados distintos para reconstituir la vacuna, a un kit de partes y a un método para permitir la reconstitución in situ de la vacuna.
UY0001032498A 2009-03-19 2010-03-17 Reconstitución in situ de una vacuna para la administración a un grupo de animales predeterminado UY32498A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16162609P 2009-03-19 2009-03-19
EP09155612 2009-03-19

Publications (1)

Publication Number Publication Date
UY32498A true UY32498A (es) 2010-10-29

Family

ID=40875190

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032498A UY32498A (es) 2009-03-19 2010-03-17 Reconstitución in situ de una vacuna para la administración a un grupo de animales predeterminado

Country Status (9)

Country Link
US (1) US20120328667A1 (es)
EP (1) EP2408430A1 (es)
JP (1) JP2012520849A (es)
CN (1) CN102341097A (es)
AR (1) AR075873A1 (es)
BR (1) BRPI1009408A2 (es)
TW (1) TW201043267A (es)
UY (1) UY32498A (es)
WO (1) WO2010106095A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2786194T3 (es) * 2013-12-03 2020-10-09 Intervet Int Bv Vacuna contra Lawsonia intracellularis y el circovirus porcino de tipo 2
KR102480771B1 (ko) 2017-10-17 2022-12-23 인터벳 인터내셔널 비.브이. 곤충 세포에서의 pcv2b orf2 단백질의 재조합 발현

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5452794A (en) * 1977-09-30 1979-04-25 Kousaku Yoshida Extracting of polysacchride from capusle containing epidermis staphylococus
JPS5459316A (en) * 1977-10-18 1979-05-12 Takeda Chem Ind Ltd Preparation of stable, freeze-dried vaccine for japanese encephalitis
JPS6013718A (ja) * 1983-07-05 1985-01-24 Chemo Sero Therapeut Res Inst Ｂ型肝炎ワクチン
JPS60193925A (ja) * 1984-03-13 1985-10-02 Chemo Sero Therapeut Res Inst 凍結乾燥製剤化ワクチン
JPH0761955B2 (ja) * 1988-04-28 1995-07-05 国立予防衛生研究所長 凍結乾燥ａ型肝炎ワクチン
AP812A (en) * 1995-06-23 2000-02-24 Smithkline Biologicals S A A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate.
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
JPH09248177A (ja) 1996-03-18 1997-09-22 Snow Brand Milk Prod Co Ltd 乾燥微生物菌体の製造法
BR9711420A (pt) 1996-09-26 1999-08-24 Akzo Nobel Nv Injetor sem agulha
IL140769A0 (en) * 1998-07-14 2002-02-10 Upjohn Co Oxazolidinones to treat eye infections
JP2002532559A (ja) * 1998-12-21 2002-10-02 アクゾ・ノベル・エヌ・ベー 不活化ｗ／ｏ乳濁液アジュバント化ワクチンの産生法
ATE520434T1 (de) 2002-06-10 2011-09-15 Intervet Int Bv Nadelloser injektor
EP1794524B1 (en) * 2004-07-23 2012-01-18 Bayer Technology Services GmbH Sterile freezing, drying, storing, assaying and filling process (sfd-saf process) (pellet freeze-drying process for parenteral biopharmaceuticals)
JP2008514644A (ja) * 2004-09-28 2008-05-08 アルザ コーポレイション ミョウバンアジュバント免疫活性剤の安定化
TWI398272B (zh) * 2005-03-08 2013-06-11 Intervet Int Bv 化學定義的安定劑
CN101095950B (zh) * 2006-06-30 2011-01-26 辽宁成大生物股份有限公司 一种稳定的人用狂犬病疫苗冻干制剂及其制备

Also Published As

Publication number Publication date
BRPI1009408A2 (pt) 2016-03-01
US20120328667A1 (en) 2012-12-27
AR075873A1 (es) 2011-05-04
TW201043267A (en) 2010-12-16
EP2408430A1 (en) 2012-01-25
JP2012520849A (ja) 2012-09-10
WO2010106095A1 (en) 2010-09-23
CN102341097A (zh) 2012-02-01

Similar Documents

Publication Publication Date Title
EA201391240A1 (ru) Слитые белки и комбинированные вакцины, содержащие белок е и пилин а haemophilus influenza
ECSP14000329A (es) Moléculas que son anticuerpos con especificidad por ox40 humano
EA201300915A1 (ru) Новый европейский штамм prrsv
EA201890942A1 (ru) Мультивалентные вакцины с синтетическими наноносителями
EP2706991A4 (en) IMMUNOGENIC COMPOSITION HAVING MULTIPLE ANTIGENS, METHODS AND USES THEREOF
EA201390804A1 (ru) Лекарственная форма лакозамида для приема один раз в сутки
CO6771458A2 (es) Conjugados de anticuerpo-fármaco
UY34176A (es) ?una construcción de adn, método para prepararla, plantas y semillas que la incluyen y métodos para generarlas?.
CO6331297A2 (es) Composiciones adyuvantes novedosas
MX2019002979A (es) Formulaciones de anticuerpos.
BR112015002981A2 (pt) vacina estável em meio líquido, e, métodos para vacinação de um canino, e para fabricar a vacina estável em meio líquido
SMT201400043B (it) Sistema, capsula e metodo per preparare una bevanda
BR112013023653A2 (pt) anticorpo biespecífico, método de preparação do anticorpo, e composição farmacêutica
CL2012003299A1 (es) Vacuna que comprende uno o mas antigenos, uno o mas oligonucleotidos inmunoestimuladores aislados y colesterol; metodo para inducir una respuesta inmune antigeno específica en un sujeto que necesita de la misma.
EA201492040A1 (ru) Бициклически замещённые урацилы и их применение
MX2013004159A (es) Proteina vp6 de la capside de norovirus y de rotavirus para el uso como vacuna combinada.
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
BR112015018877A2 (pt) Método para preparar uma composição farmacêutica, e, composição farmacêutica imunogênica
BRPI0808037A2 (pt) Preparação liofilizada contendo vacina contra gripe e método para preparação da mesma.
CO2017000558A2 (es) Variantes de proteínas de unión al factor h
DK3564378T3 (da) Immunogen sammensætning
BR112014005875A2 (pt) método, sistema e cápsula para preparar uma bebida
EA201692554A1 (ru) Менингококковые вакцины
WO2013177444A3 (en) Influenza vaccine constructs
BRPI0919485A2 (pt) vacinas, antígenos, composições de plasmodium e métodos

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20130125